Optimizing BTKi Patient Outcomes via a NEW Digital Tool
Coming soon
Coming soon
Thursday, April 3, 2025
12:30-14:00
Latest Learnings and Best Practices with the Implementation of Bispecific Antibodies for Multiple Myeloma
14:15-15:15
Impact of Immunotherapy in Frontline B-ALL: A Pharmacist’s Perspective
15:30-16:30
Innovative Technologies for Safe and Economical Handling of Hazardous Drugs: New Frontiers in Automation, CSTD Vapor Containment, and Drug Sterility in the Modern Pharmacy
16:45-17:45
Treatment-Related Adverse Events of Antibody–Drug Conjugates, Integrating and Managing Novel Therapies in Practice
Friday, April 4, 2025
7:15-08:45
PARP Inhibitor Pan Tumour Clinical Resource: Supporting Oncology Pharmacists in Managing Breast, Ovarian, Pancreatic and Prostate Cancers
12:30-14:00
Considerations for Improving the Efficiency of Administration in Clinical Practice of Various Multiple Myeloma Therapies
17:00-18:30
Does Your Hazardous Drug List Adequately Address the Risks Associated with Handling Hazardous Drugs?
Saturday, April 5, 2025
7:15-08:45
Ensuring Safety: Applying Research to Help Maximize Protection from Hazardous Drugs
12:30-14:00
Subcutaneous Administration of Immunotherapy in Different Care Settings
16:45-18:15
Dose Banding in Oncology
Sunday, April 6, 2025
7:15-08:45
Espresso Shot Learning: Hot Topics and Updates in Oncology
13:00-14:30
The Role of Innovative Biosimilars and Generics in Improving Health Equity + HOPE Awards in Pharmacy
14:30-15:30
Innovative Models of Care in Breast Cancer - the Canadian Experience